rs1057519413
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_002875.5(RAD51):c.877G>A(p.Ala293Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. A293A) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 31)
Consequence
RAD51
NM_002875.5 missense
NM_002875.5 missense
Scores
11
5
3
Clinical Significance
Conservation
PhyloP100: 9.61
Genes affected
RAD51 (HGNC:9817): (RAD51 recombinase) The protein encoded by this gene is a member of the RAD51 protein family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51, and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with the ssDNA-binding protein RPA and RAD52, and it is thought to play roles in homologous pairing and strand transfer of DNA. This protein is also found to interact with BRCA1 and BRCA2, which may be important for the cellular response to DNA damage. BRCA2 is shown to regulate both the intracellular localization and DNA-binding ability of this protein. Loss of these controls following BRCA2 inactivation may be a key event leading to genomic instability and tumorigenesis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PP2
?
Missense variant where missense usually causes diseases, RAD51
PP3
?
MetaRNN computational evidence supports a deleterious effect, 0.924
PP5
?
Variant 15-40729955-G-A is Pathogenic according to our data. Variant chr15-40729955-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 372139.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-40729955-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RAD51 | NM_002875.5 | c.877G>A | p.Ala293Thr | missense_variant | 9/10 | ENST00000267868.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RAD51 | ENST00000267868.8 | c.877G>A | p.Ala293Thr | missense_variant | 9/10 | 1 | NM_002875.5 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 31
GnomAD3 genomes
?
Cov.:
31
GnomAD4 exome Cov.: 33
GnomAD4 exome
Cov.:
33
GnomAD4 genome ? Cov.: 31
GnomAD4 genome
?
Cov.:
31
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
RAD51-related condition Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 20, 2022 | The RAD51 c.880G>A variant is predicted to result in the amino acid substitution p.Ala294Thr. This variant has been reported as arising de novo in an individual with microcephaly and intellectual disability, and described as atypical Fanconi anemia (reported as p.Ala293Thr in alternate transcript NM_002875 in Ameziane et al. 2015. PubMed ID: 26681308). Functional studies from this same report using protein expression in cultured cells indicate that the p.Ala294Thr substitution has a dominant negative effect on the wild-type protein (Ameziane et al. 2015. PubMed ID: 26681308). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Given the evidence, we interpret c.880G>A (p.Ala294Thr) as likely pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2016 | - - |
Fanconi anemia complementation group R Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 10, 2020 | - - |
RAD51-related disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Aug 25, 2020 | This variant has been previously reported as a de novo alteration in a patient with an atypical Fanconi Anemia who presented with growth retardation, microcephaly, hydrocephalus, skeletal (thumb and radius) abnormalities, imperforate anus and an improperly formed left testicle (NM_002875.3: c.877G>A, p.A293T; PMID: 26681308). In vitro characterization of this alteration via functional assays and biochemical studies demonstrated that the variant acts in a dominant-negative manner leading to impaired DNA binding and strand exchange activity as well as impaired ATP hydrolysis. Furthermore, patient's cells were sensitive to DNA crosslinking agents (PMID: 26681308). The c.880G>A p.Ala294Thr variant is absent from the gnomAD population database and thus is presumed to be rare. It affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.880G>A (p.Ala294Thr) variant is classified as Pathogenic. - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | curation | Leiden Open Variation Database | Mar 15, 2014 | Curator: Arleen D. Auerbach. Submitter to LOVD: Najim Ameziane. Comment: Variant observed de novo. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M;.;.;.
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
D;.;.;.
Vest4
MutPred
Gain of glycosylation at A293 (P = 0.1028);.;.;.;
MVP
MPC
2.0
ClinPred
D
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at